Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 55
- +6 vs. Q2 2021
- Portfolio value
- $303.3M
- −$16.5M (−5.2%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ASNDAscendis Pharma A/S | SPONSORED ADR | 120,000 | $19.1M | 6.3% | −15,000−11.1% | Reduced | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 700,000 | $17.3M | 5.7% | +250,000+55.6% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 255,000 | $13.8M | 4.5% | −30,000−10.5% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 1,500,000 | $12.6M | 4.2% | −100,000−6.3% | Reduced | History |
| ARVNArvinas, Inc. | COM | 150,000 | $12.3M | 4.1% | −55,000−26.8% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 790,000 | $12.1M | 4.0% | −60,000−7.1% | Reduced | History |
| ISEEIVERIC bio, Inc. | COM | 725,000 | $11.8M | 3.9% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 575,000 | $11.0M | 3.6% | −300,000−34.3% | Reduced | History |
| MRTXMirati Therapeutics, Inc. | COM | 60,000 | $10.6M | 3.5% | +10,000+20.0% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 350,000 | $10.5M | 3.4% | +225,000+180.0% | Added | History |
| ALLKAllakos Inc. | COM | 85,000 | $9.00M | 3.0% | +85,000 | New | History |
| GHRSGH Research PLC | ORDINARY SHARES | 400,000 | $8.82M | 2.9% | +400,000 | New | History |
| KURAKura Oncology, Inc. | COM | 425,000 | $7.96M | 2.6% | −275,000−39.3% | Reduced | History |
| RAPTRAPT Therapeutics, Inc. | COM | 250,000 | $7.76M | 2.6% | −320,000−56.1% | Reduced | History |
| CYPHCypherpunk Technologies Inc. | COM | 1,650,000 | $6.62M | 2.2% | +1,650,000 | New | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 200,000 | $6.59M | 2.2% | +200,000 | New | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 700,000 | $6.15M | 2.0% | +100,000+16.7% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 350,000 | $5.76M | 1.9% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,000,000 | $5.48M | 1.8% | 00.0% | Unchanged | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 150,000 | $5.26M | 1.7% | +150,000 | New | History |
| RLMDRelmada Therapeutics, Inc. | COM | 200,000 | $5.24M | 1.7% | +200,000 | New | History |
| ACRSAclaris Therapeutics, Inc. | COM | 275,000 | $4.95M | 1.6% | +25,000+10.0% | Added | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $4.94M | 1.6% | 00.0% | Unchanged | History |
| CTICCti Biopharma Corp | COM | 1,600,000 | $4.72M | 1.6% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 250,000 | $4.62M | 1.5% | +250,000 | New | History |
| SRRASierra Oncology, Inc. | COM NEW | 200,000 | $4.38M | 1.4% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 65,000 | $4.33M | 1.4% | +65,000 | New | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $4.21M | 1.4% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 100,000 | $4.16M | 1.4% | −100,000−50.0% | Reduced | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $4.11M | 1.4% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 750,000 | $4.11M | 1.4% | −250,000−25.0% | Reduced | History |
| TCRRTCR2 Therapeutics Inc. | COM | 477,323 | $4.06M | 1.3% | +477,323 | New | History |
| PCVXVaxcyte, Inc. | COM | 160,000 | $4.06M | 1.3% | +15,000+10.3% | Added | History |
| ALLOAllogene Therapeutics, Inc. | COM | 150,000 | $3.85M | 1.3% | −125,000−45.5% | Reduced | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 170,000 | $3.66M | 1.2% | 00.0% | Unchanged | History |
| NMTR9 Meters Biopharma, Inc. | COM | 2,750,000 | $3.58M | 1.2% | +2,750,000 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 150,000 | $3.16M | 1.0% | −93,309−38.3% | Reduced | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 100,000 | $2.99M | 1.0% | +100,000 | New | History |
| FATEFate Therapeutics Inc | COM | 50,000 | $2.96M | 1.0% | −135,000−73.0% | Reduced | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 75,000 | $2.88M | 0.9% | −50,000−40.0% | Reduced | History |
| FOLDAmicus Therapeutics, Inc. | COM | 265,000 | $2.53M | 0.8% | 00.0% | Unchanged | History |
| Bellus Health Inc New07987C204 | COM NEW | 400,000 | $2.46M | 0.8% | +400,000 | New | – |
| IMUXImmunic, Inc. | COM | 265,000 | $2.35M | 0.8% | 00.0% | Unchanged | History |
| LRMRLarimar Therapeutics, Inc. | COM | 200,000 | $2.31M | 0.8% | +100,000+100.0% | Added | History |
| MRNAModerna, Inc. | Stock | 5,300 | $2.04M | 0.7% | +1,300+32.5% | Added | History |
| ALECAlector, Inc. | COM | 80,000 | $1.83M | 0.6% | +80,000 | New | History |
| MRUSMerus N.V. | COM | 75,000 | $1.65M | 0.5% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 50,000 | $1.41M | 0.5% | +50,000 | New | History |
| CMRXChimerix Inc | COM | 200,000 | $1.24M | 0.4% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 100,000 | $1.22M | 0.4% | +100,000 | New | History |
| OTICOtonomy, Inc. | COM | 450,000 | $864.0K | 0.3% | 00.0% | Unchanged | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $774.0K | 0.3% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 2,000 | $546.0K | 0.2% | +2,000 | New | History |
| TBIOTelesis Bio Inc. | COM | 35,000 | $390.0K | 0.1% | 00.0% | Unchanged | History |
| PRVBProvention Bio, Inc. | COM | 50,000 | $320.0K | 0.1% | −50,000−50.0% | Reduced | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q2 2021 (10)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| Trillium Therapeutics Inc.89620X506 | COM NEW | 1,250,000 | $12.1M | 3.8% | – |
| BIIBBiogen Inc. | COM | 32,500 | $11.3M | 3.5% | History |
| TGTXTG Therapeutics, Inc. | COM | 180,000 | $6.98M | 2.2% | History |
| MRSNMersana Therapeutics, Inc. | COM | 450,000 | $6.11M | 1.9% | History |
| EPIXESSA Pharma Inc. | COM NEW | 207,500 | $5.93M | 1.9% | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 75,000 | $5.17M | 1.6% | History |
| KDMNKadmon Holdings, Inc. | COM | 800,000 | $3.10M | 1.0% | History |
| CRISCuris Inc | COM NEW | 247,124 | $1.99M | 0.6% | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 75,000 | $1.92M | 0.6% | History |
| ELEVElevation Acquisition Group Inc. | COM | 100,000 | $1.36M | 0.4% | History |